10 Takeover Targets to Watch This Fall
Pace of Biopharma M&A Slows from First Half Stampede of Deals
Vertex’s David Altshuler Humanizes Drug Discovery
Lessons from Vertex’s Small Molecule Drug Development Program for Cystic Fibrosis
Scaling Up Cell Therapy Manufacturing
Moving Forward with an Early-on Strategy
Marijuana Use in Adults Living with Sickle Cell Disease
Most States Do Not Specify Sickle Cell Disease as a Qualifying Condition for Legal Access to Marijuana
For full access to this article login to GEN Select now.
Aseptic Filling Adjusting to New Paradigm
Complex and Sensitive Drugs Necessitate High-Tech Manufacturing Operations
- Aseptic filling—the final step before packaging parenteral small molecule and biotherapeutic drugs—represents one of the most technologically innovative and dynamic areas of downstream operations. Filling operations are changing in response to larger industry trends, explains Peter Soelkner, managing director of Vetter Pharma. “Pharmaceutical development is evolving toward highly ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.